Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000802117 | SCV000941933 | uncertain significance | Autosomal dominant Parkinson disease 8 | 2020-02-22 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with LRRK2-related disease. This variant is present in population databases (rs201935017, ExAC 0.002%). This sequence change replaces asparagine with aspartic acid at codon 1062 of the LRRK2 protein (p.Asn1062Asp). The asparagine residue is weakly conserved and there is a small physicochemical difference between asparagine and aspartic acid. |